Therapeutic effect of diagnostic ultrasound on enzymatic thrombolysis

Summary

If delivered at elevated intensity, ultrasound potentiates enzymatic clot dissolution; however, an elevated acoustic intensity damages vascular wall and favors reocclusion. This study’s aim was to investigate whether exposure to high-frequency, lowintensity ultrasound generated by a diagnostic scanner enhances enzymatic thrombolysis, and if this effect differs in clots from blood of normal subjects and of patients with coronary artery disease (CAD). Venous blood samples were drawn from 10 healthy volunteers and from 10 CAD patients on chronic medical treatment, which also included aspirin. Each sample generated 2 radiolabelled clots, which were positioned in 2 in vitro models filled with human plasma recirculating at 37°. One clot was exposed to acetyl salicylic acid (60 μg/ml), tissue plasminogen activator (3 μg/ml) and heparin (1 IU/ml), while the other was exposed to the same medications plus ultrasound (2.5 MHz, mechanical index = 1.0) for 3 hours. Enzymatic thrombolysis was measured as solubilization of radiolabel. Normal subjects and patients did not significantly differ as to coagulation parameters, weight, volume and density of the clots, and fibrinolytic activity (p = 0.794). Ultrasound exposure did not influence thrombolysis in clots of normal subjects (p = 0.367), while it enhanced the dissolution of clots of CAD patients (p = 0.013). The enhancement was equal to 51% at 5 minutes, 32% at 15 minutes, 27% at 30 minutes, 20% at 1 hour and 19% at 3 hours (p < 0.05). Diagnostic ultrasound enhances enzymatic dissolution of clots generated from the blood of CAD patients, likely due to chronic treatment and in particular to aspirin.

Keywords

Thrombosis - ultrasound - thrombolysis - microbubbles

• References

• 1 Siegel RJ. Therapeutic ultrasound, part I. Echocardiography 2001; 18: 211-2.
• 2 Rovai D, Basta G, Lazzerini G. et al. Thrombolysis accelerated by ultrasound and microbubbles. Ital Heart J 2003; 04: 407-14.
• 3 Gaul GB. Ultrasound thrombolysis. Thromb Haemost 1999; 82: 157-9.
• 4 Daffertshofer M, Hennerici M. Ultrasound in the treatment of ischaemic stroke. Lancet Neurol 2003; 02: 283-90.
• 5 Nyborg WL. Biological effect of ultrasound: development of safety guidelines. Part II: general review. Ultrasound Med Biol 2001; 27: 301-33.
• 6 Lauer CG, Burge R, Tang DB. et al. Effect of ultrasound on tissue-type plasminogen activator-induced thrombolysis. Circulation 1992; 86: 1257-64.
• 7 Francis CW, Onundarson PT, Carstensen EL. et al. Enhancement of fibrinolysis in vitro by ultrasound. J Clin Invest 1992; 90: 2063-8.
• 8 Blinc A, Francis CW, Trudnowski JL. et al. Characterization of ultrasound-potentiated fibrinolysis in vitro . Blood 1993; 81: 2636-43.
• 9 Behrens S, Spengos K, Daffertshofer M. et al. Transcranial ultrasound-improved thrombolysis: diagnostic vs. therapeutic ultrasound. Ultrasound Med Biol 2001; 27: 1683-9.
• 10 Kornowski R, Meltzer RS, Chernine A. et al. Does external ultrasound accelerate thrombolysis? Results from a rabbit model. Circulation 1994; 89: 339-44.
• 11 Riggs PN, Francis CW, Bartos SR. et al. Ultrasound enhancement of rabbit femoral artery thrombolysis. Cardiovasc Surg 1997; 05: 201-7.
• 12 Rosenschein U, Furman V, Kerner E. et al. Ultrasound imaging-guided noninvasive ultrasound thrombolysis: preclinical results. Circulation 2000; 102: 238-45.
• 13 Suchkova VN, Baggs RB, Francis CW. Effect of 40-kHz ultrasound on acute thrombotic ischemia in a rabbit femoral artery thrombosis model: enhancement of thrombolysis and improvement in capillary muscle perfusion. Circulation 2000; 101: 2296-301.
• 14 Siegel RJ, Atar S, Fishbein MC. et al. Noninvasive transcutaneous low frequency ultrasound enhances thrombolysis in peripheral and coronary arteries. Echocardiography 2001; 18: 247-57.
• 15 Atar S, Luo H, Birnbaum Y. et al. Augmentation of in-vitro clot dissolution by low frequency high-intensity ultrasound combined with antiplatelet and antithrombotic drugs. J Thromb Thrombolysis 2001; 11: 223-8.
• 16 Jafri SM, Walters BL, Borzak S. Medical therapy of acute myocardial infarction: Part I. Role of thrombolytic and antithrombotic therapy. J Intensive Care Med 1995; 10: 54-63.
• 17 Szekendi MK. Compliance with acute MI guidelines lowers inpatient mortality. J Cardiovasc Nurs 2003; 18: 356-9.
• 18 Luo H, Nishioka T, Fishbein MC. et al. Transcutaneous ultrasound augments lysis of arterial thrombi in vivo . Circulation 1996; 94: 775-8.
• 19 He S, Blomback M, Yoo G. et al. Modified clotting properties of fibrinogen in the presence of acetylsalicylic acid in a purified system. Ann N Y Acad Sci 2001; 936: 531-5.
• 20 Fatah K, Silveira A, Tornvall P. et al. Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at a young age. Thromb Haemost 1996; 76: 535-40.
• 21 Jorneskog G, Egberg N, Fagrell B. et al. Altered properties of the fibrin gel structure in patients with IDDM. Diabetologia 1996; 39: 1519-23.
• 22 Fatah K, Beving H, Albage A. et al. Acetylsalicylic acid may protect the patient by increasing fibrin gel porosity. Is withdrawing of treatment harmful to the patient?. Eur Heart J 1996; 17: 1362-6.
• 23 Williams S, Fatah K, Hjemdahl P. et al. Better increase in fibrin gel porosity by low dose than intermediate dose acetylsalicylic acid. Eur Heart J 1998; 19: 1666-72.
• 24 Braaten JV, Goss RA, Francis CW. Ultrasound reversibly disaggregates fibrin fibers. Thromb Haemost 1997; 78: 1063-8.
• 25 Porter TR, LeVeen RF, Fox R. et al. Thrombolytic enhancement with perfluorocarbon-exposed sonicated dextrose albumin microbubbles. Am Heart J 1996; 132: 964-8.